Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan vs Valsartan in African Americans with Impaired Glucose Tolerance
NCT03938389Phase 4Active, not recruiting
- Sponsor
- The Ohio State University
- Start
- Feb 2020
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sacubitril + valsartan in impaired glucose tolerance (IGT), sponsored by The Ohio State University. Started Feb 2020; status: active, not recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT03938389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03938389.